摘要
目的：分析全国6个地区他汀类调脂药物使用情况及趋势,为临床合理用药提供参考。方法：对北京、上海等6个地区2013年84医院他汀类销售额、处方数、用药频度、日均费用、实际日剂量、取药量/处方数及不同类型（国产、进口及合资）药物进行统计分析。结果：综合各地区,60~74岁年龄段人群他汀类使用量最大且女性〉男性。阿托伐他汀的销售金额和使用量均居于首位,但日均费用也较高,瑞舒伐他汀次之,辛伐他汀虽用量不大,但最为经济。国产药种类较多,使用量却低于合资药和进口药。结论：他汀类是治疗高脂血症的一线用药,拥有广阔的市场前景。
Objective： Through analyzing the situation and developing trend of the utilization of stains in six areas of China, to lay a foundation for clinically rational drug use. Methods： The utilization of statins in 84 hospitals in six areas such as Beijing, Shanghai and so on were analyzed statistically in respect of sales, prescrip- tions, daily defined doses, defined daily cost, actual average daily dose, ratio between drug quantitise and pre- scriptions, different kinds of （domestic and sino-foreign joint venture and imported） drugs in 2013. Results： The age group of 60 ~ 74 showed the highest usage of statins and the usage of males was higher than females in all re- gions. At the same time the sales and usage of atorvastatin were in the first place while their daily cost was the high- est, and the second was rosuvastatin. Although the usage of simvastatin was lower, they were the most economical. The phenomenon was that the usage of sino-foreign joint venture drugs and imported drugs were greater than that of domestic drugs. However categories of domestic drugs were more. Conclusion： Statins are first-line drugs in the treatment of hyperlipidemia, having a great potential.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2015年第9期1074-1080,共7页
Chinese Journal of New Drugs
关键词
他汀类
销售额
用药频度
日均费用
statins
sales
daily defined doses
defined daily cost
